Nussbaum Named to PhyMed Board

NASHVILLE, Tenn., Dec. 13, 2016 /PRNewswire/ -- Dr. Sam Nussbaum, an executive with extensive expertise across the spectrum of healthcare, has been named to the board of PhyMed Healthcare Group, a physician-led and owned leader of anesthesia and pain management services.

Dr. Nussbaum's work has placed him at the center of healthcare transformation. He has leadership experience in population health, quality, health outcomes, care management, data analytics, provider contracting and medical and pharmacy policy.

From 2000 to 2016, Dr. Nussbaum served as Executive Vice President, Clinical Health Policy, and Chief Medical Officer for Anthem, where he was the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy.  During his tenure at Anthem, he was responsible for over $100 billion in annual healthcare expenditures through business units focused on care and disease management, health improvement and provider network contracting. 

Prior to Anthem, he was Executive Vice President, Medical Affairs and System Integration for BJC HealthCare, where he led integrated clinical services and served as president of its medical group and chairman of its commercial and Medicaid health plans.

Prior to BJC, Nussbaum, an endocrinologist, was a professor at Harvard Medical School and a physician at Massachusetts General Hospital, where he had a 20-year academic career in basic science, drug discovery, clinical studies, teaching and patient care. He has been recognized by Modern Healthcare as one of the "50 Most Influential Physician Executives in Healthcare."

"We are very excited to welcome Dr. Nussbaum to our board.  His numerous achievements position him to offer valuable strategic guidance and advice to our company," said Sami Abbasi, president and chief executive officer of PhyMed. "Sam brings deep knowledge of the drivers of healthcare costs and has been an influential voice in the healthcare reform dialogue.  He has strong relationships with hospitals and health systems, physician organizations and insurers and will be instrumental in helping us to continue to refine our strategy and accelerate our growth."

"PhyMed's vision of building an industry-leading, best-in-class anesthesia services company — one that is physician-led and owned — is a true differentiator and offers anesthesiology practices an opportunity to partner with PhyMed," said Dr. Nussbaum.  "What attracted me to PhyMed is the management and clinical teams' unwavering commitment to clinical excellence and quality.  Many organizations talk about quality, but PhyMed lives it in its care of thousands of patients each day.  I look forward to supporting PhyMed's continued growth and exceptional patient care." 

Dr. Nussbaum currently serves as a member of the Guiding Committee of the Learning and Action Network, a public-private initiative established by the Department of Health and Human Services, and chaired its work group that developed the framework for alternate payment models to enhance patient-centered care and smarter health care spending. Dr. Nussbaum is a Senior Fellow at the USC Schaeffer Center for Health Policy and Economics.  

About PhyMed Healthcare Group

Based in Nashville, Tennessee, PhyMed Healthcare Group is one of the leading organizations providing anesthesia and perioperative care in the United States.  It is a physician-led and owned leader of anesthesia and pain management services, and is committed to providing focused, proactive and innovative business solutions that foster high-quality, care-centered results. PhyMed Healthcare Group is a trusted partner proudly serving healthcare systems, ambulatory surgery centers and office-based anesthesia in multiple states.  To learn more, visit www.PhyMed.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nussbaum-named-to-phymed-board-300377616.html

SOURCE PhyMed Healthcare Group